REGENXBIO
RGNX
#7517
Rank
โ‚น47.51 B
Marketcap
โ‚น718.62
Share price
-4.86%
Change (1 day)
-27.22%
Change (1 year)

EPS for REGENXBIO (RGNX)

EPS in 2026 (TTM): -โ‚น296.15

According to REGENXBIO's latest financial reports the company's current EPS (TTM) is -โ‚น301.93. In 2025 the company made an earnings per share (EPS) of -โ‚น353.67 an increase over its 2024 EPS that were of -โ‚น433.62.

EPS history for REGENXBIO from 2015 to 2026

Annual EPS

Year EPS Change
2026 (TTM)-โ‚น296.15-16.26%
2025-โ‚น353.67-18.44%
2024-โ‚น433.62
2022-โ‚น611.39-321.09%
2021โ‚น276.54-198.33%
2020-โ‚น281.2415.44%
2019-โ‚น243.62-181.19%
2018โ‚น300.05-229.15%
2017-โ‚น232.333.35%
2016-โ‚น224.805.42%
2015-โ‚น213.25

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
ORIC Pharmaceuticals
ORIC
-โ‚น126.98-57.94%๐Ÿ‡บ๐Ÿ‡ธ USA